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GCAGAAGG-3′) in the csp gene of 
Pkpah-1. Furthermore, the alignment 
showed 21 variable sites between the 
genes. Phylogenetic analysis based on 
SSU rRNA sequences indicated that 
Pkpah-1 and Pkprk-1 formed a cluster, 
which was more related to P. knowlesi 
isolates from Thailand than to isolates 
from Sarawak, a Malaysian state 
in Borneo Island (Figure). Another 
isolate from Peninsular Malaysia, 
KAL-1, was also grouped with 
Pkpah-1 and Pkprk-1. The KAL-1 
isolate was detected in a traveler from 
Finland returning from Peninsular 
Malaysia in 2007 (7).
P. knowlesi infection does 
not relapse because the parasite 
has no liver hypnozoite stage (8). 
Reinfection and recrudescence are not 
uncommon in malaria. The fi nding 
in the patient reported here indicates 
reinfection rather than recrudescence 
as confi rmed by PCR genotyping. He 
acquired his infection while jungle 
trekking in Raub in October 2009 and 
was reinfected in Tanjung Malim in 
June 2010 (the great-circle distance 
between the 2 locations is 38.61 km). 
This case shows that immunity toward 
P. knowlesi infection is strain specifi c 
as has been observed in other malaria 
species (9). P. knowlesi is a nonhuman 
primate malaria species, and humans 
are accidental hosts when they go 
into areas where macaques dwell. P. 
knowlesi can cause reinfection and can 
potentially be severe in areas where it 
is endemic. Travelers to forested areas 
of endemicity should be advised to 
take strict antimosquito measures and 
prophylaxis. Physicians should be 
aware that P. knowlesi infection is a 
vital differential diagnosis in febrile 
travelers with a recent travel history to 
forested areas in Southeast Asia.
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To the Editor: The ≈20 recog-
nized arenaviruses in the Americas 
are hosted by rodents of the family 
Cricetidae; 1 exception may be hosted 
by a bat (genus Artibeus, family 
Phyllostomidae) (1). Pichindé virus, 
hosted by Oryzomys albigularis, 
was described from animals in the 
Pichindé Valley near Cali, Colombia 
(2), and antibody reactive to Pichindé 
virus was found in 2 of 82 serum 
samples from humans in the same 
area. No studies of arenavirus 
infection in rodents or humans have 
been conducted in Colombia since 
1971. Although Pichindé virus is 
not associated with human disease, 
Guanarito virus, which is hosted 
by Zygodontomys brevicauda, the 
short-tailed cane mouse (3,4), causes 
Venezuelan hemorrhagic fever in the 
Venezuelan state of Portuguesa (5). 
This state borders on Colombia, and 
Z. brevicauda is a common species in 
Caribbean Colombia. Our aim was to 
determine the prevalence of antibody 
to arenaviruses among wild rodents in 
this region.
During November 1, 2008–June 
10, 2009, we trapped 322 rodents in 
3 rural localities in the Department 
of Córdoba, Colombia (Monteria, 
Vereda El Escondido, 8°34.183′N, 
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75°42.776′W; Sahagun, Vereda Las 
Llanadas, 8°56.533′N, 75°20.909′W; 
and Lorica, Colegio Instituto Técnico 
Agrícola, 9°24.067′N, 075°75.707′W). 
The landscape at the study sites is 
dominated by tropical savanna, small 
patches of forest, and cultivated 
land. Live-capture traps were set in 
a variety of habitats at each locality, 
and captured rodents were processed 
according to methods by Mills et al. 
(6). Rodents were anesthetized, and 
blood (by cardiac puncture) and tissue 
(liver, lung, spleen, hearty, kidney) 
samples were collected into individual 
cryovials, placed in liquid nitrogen in 
the fi eld, and transferred to freezers 
and stored at –80°C at the Instituto 
de Investigaciones Biológicas del 
Trópico, Universidad de Córdoba, 
Montería, Colombia. Rodent species 
were identifi ed on the basis of 
morphologic analyses of formalin-
fi xed carcasses; chromosomal data 
and mitochondrial DNA sequencing 
of the cytochrome b gene were used 
to confi rm identifi cation of most 
antibody-positive animals. Alcohol-
preserved voucher specimens are 
archived at the Museum of Texas Tech 
University (Lubbock, TX, USA).
Blood samples were tested for 
arenavirus immunoglobulin (Ig) G
by indirect immunofl uorescent 
antibody assays. Guanarito and 
Pichindé virus–infected Vero E6 
cells were used as antigens on spot 
slides. The secondary antibody 
was a fl uorescein-conjugated goat, 
antimouse IgG. Serum samples were 
screened at a dilution of 1:10 and 
endpoint titers were measured by using 
serial 2-fold dilutions (1:10–1:320) 
(7). Attempts to amplify viral RNA in 
tissues by reverse transcription PCR 
were unsuccessful.
We collected 210 sigmodontine 
rodents of 3 species: 181 Z. brevicauda, 
28 Oligoryzomys fulvescens, and 1 
Oecomys concolor. Eleven serum 
samples, 10 from Z. brevicauda and 
1 from O. fulvescens rodents, had 
detectable arenavirus antibody. Three 
Z. brevicauda rodent samples had 
antibody reactive to both Pichindé 
and Guanarito virus, and 7 more 
were positive for either Pichindé or 
Guanarito arenaviruses (Table).
We used only 2 viral antigens 
in our screening belonging to the 
2 viruses that are either known to 
occur in Colombia (Pichindé virus) 
or known to be hosted by species 
that we captured (Guanarito virus). 
Among the 10 Z. brevicauda samples 
with detectable antibody, 5 reacted 
only to Pichindé virus antigen or their 
antibody titer to Pichindé virus was at 
least 4-fold higher than their titer to 
Guanarito virus (Table), suggesting 
those rodents were infected with 
Pichindé or a closely related virus. 
Additional studies, including isolation 
and sequencing are needed to 
defi nitively identify this virus.
Surprisingly, only 2 Z. brevicauda 
rodent (1.1%) had antibody only to 
Guanarito virus or had a 4-fold greater 
titer to Guanarito virus, much lower 
than the 15% antibody prevalence in 
the same species in the Venezuelan 
hemorrhagic fever–endemic area, 
Portuguesa State, Venezuela (5). 
Our testing protocols differed from 
the earlier study, and we have not 
defi nitively identifi ed Guanarito virus 
in those 3 rodents; nevertheless, this 
low prevalence might help explain the 
absence of Venezuelan hemorrhagic 
fever in Colombia, although 
inadequate surveillance is a second 
possible explanation.
The single antibody-positive O. 
fulvescens rodent had a low antibody 
titer only to Pichindé virus. This 
apparent 4% antibody prevalence 
is based on only 28 mice. The 
signifi cance of this fi nding is not 
clear but may represent spillover or 
an undescribed arenavirus specifi c 
to the species O. fulvescens. Again, 
additional studies are needed.
Our results demonstrate the 
presence of >1 arenaviruses cir-
culating among common rodent hosts 
in Caribbean Colombia. We emphasize 
that many New World arenaviruses are 
likely cross-reactive to the antigens 
we used; recovery and sequencing 
of viral RNA will be essential to 
fully characterize these viruses. 
Hemorrhagic fever of arenaviral origin 
should be included in the differential 
diagnosis of tropical fevers, at least 
in our study region. As the human 
population of the rural Department 
of Córdoba and adjacent areas of 
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Table. Comparison of PICHV and GTOV antibody titers in rodents after serologic screening of 210 sigmodontine rodents, Córdoba, 
Colombia, November 1, 2008–June 10, 2009* 
Specimen no. Species PICHV titer GTOV titer Rural locality 
49 Zygodontomys brevicauda 40 <10 Monteria
70 Z. brevicauda 80 10 Monteria
105 Z. brevicauda 40 <10 Monteria
107 Oligoryzomys fulvescens 20 <10 Monteria
272 Z. brevicauda 80 10 Monteria
289 Z. brevicauda 20 <10 Monteria
317 Z. brevicauda 40 <10 Monteria
344 Z. brevicauda 20 <10 Monteria
345 Z. brevicauda <10 20 Monteria
209 Z. brevicauda 10 80 Lorica
211 Z. brevicauda <10 40 Lorica
*PICHV, Pichindé arenavirus; GTOV, Guanarito arenavirus. Titers in boldface are >4-fold higher than titers for the other antigen. 
LETTERS
the Caribbean coast of Colombia 
continues to increase, the potential 
for arenavirus-related disease could 
become a public health concern.
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To the Editor: Bangladesh has 
achieved remarkable success in its 
drive to eliminate poliomyelitis; 
no case has been reported from 
that country since 2000. Still, the 
nonpolio incidence rate of acute 
fl accid paralysis (AFP) in Bangladesh 
is 3.25 cases per 100,000 children 
<15 years of age (1). Guillain–
Barré syndrome (GBS), an acute 
polyradiculoneuropathy, is the most 
frequent cause of AFP (2). GBS in 
Bangladesh is frequently preceded 
by an enteric infection caused by 
Campylobacter jejuni (3). Frequent 
exposure to enteric pathogens at an 
early age may increase the incidence 
of GBS. We hypothesized that most 
AFP cases in Bangladesh can be 
diagnosed as GBS. Our objective was 
to estimate the crude incidence rate 
of GBS among children <15 years of 
age in Bangladesh.
In collaboration with the World 
Health Organization (WHO), the 
Government of Bangladesh conducts 
active AFP surveillance. AFP is 
defi ned as acute onset of focal or 
general fl accid (hypotonic) weakness 
without other obvious cause (e.g., 
trauma) in children <15 years of age. 
Data on the number of reported AFP 
cases in Bangladesh during 2006 and 
2007 were obtained. On the basis 
of clinical and other information 
routinely collected through the 
surveillance system, we defi ned a GBS 
case as presence of an acute fl accid 
(hypotonic) paralysis and symmetrical 
weakness (4) in the absence of injury 
or birth trauma.
Bangladesh is divided into 6 
divisions (major administrative 
regions) comprising 64 districts. 
Crude incidence data for GBS were 
calculated per division and per district 
on the basis of the population <15 
years of age reported by WHO and the 
Government of Bangladesh.
In 2006 and 2007, a total of 1,619 
and 1,844 AFP cases, respectively, 
were reported in children <15 years 
of age, of which 608 (37%) and 855 
(46%) cases, respectively, fulfi lled 
the GBS case defi nition. The crude 
incidence rate for GBS in children 
<15 years of age varied from 1.5 to 1.7 
cases per 100,000 population in the 3 
northern divisions (Dhaka, Rajshahi, 
and Sylhet) and from 2.1 to 2.5 per 
100,000 in the 3 southern divisions 
(Khulna, Barisal, and Chittagong) 
(online Appendix Figure, www.cdc.
gov/EID/content/17/7/1317-appF.
htm). Overall, the crude incidence 
rate of GBS in children <15 years of 
age varied from 1.5 to 2.5 cases per 
100,000 population per year in the 6 
divisions of Bangladesh. Incidence 
rates were high (>5.0/100,000) in 
the Meherpur and Barisal districts 
in southern Bangladesh. We found a 
seasonal fl uctuation in the frequency 
of patients with GBS; the most cases 
occurred in May (n = 159) and the 
lowest in February (n = 84). GBS 
occurred predominantly among boys 
(59%).
Most incidence studies reported 
in the literature originate from 
Europe and North America (5). A 
recent review reported that the best 
estimate of the global incidence of 
GBS in children <15 years of age is 
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